NCT07585643

Brief Summary

When children have surgery, anaesthetists carefully monitor the depth of anaesthesia by using sensors on the forehead that measure brain activity, also known as processed electroencephalogram (pEEG). These monitors are routinely used in paediatric anaesthesia; however, we do not know if they work accurately in babies and young children with seizure disorders or on anti-seizure medications. Children with developmental and epileptic encephalopathies may need anaesthesia for tests or procedures. It is important that their treating doctors understand whether these monitors truly reflect how awake or asleep the children are. This study aims to compare a child's electrical brain activity using two commonly used devices in paediatric anaesthesia with the conventional 21-lead EEG patterns in children with seizure disorders. The results of this research may help improve the safety and perioperative care of children with seizure disorders who require general anaesthesia in the future.

Trial Health

67
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
38mo left

Started May 2026

Typical duration for all trials

Geographic Reach
2 countries

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 14, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

May 20, 2026

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2029

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2029

Last Updated

May 14, 2026

Status Verified

April 1, 2026

Enrollment Period

3 years

First QC Date

May 6, 2026

Last Update Submit

May 6, 2026

Conditions

Keywords

epileptic encepthalopathyanaesthesiaPILOT STUDYMULTICENTRE

Outcome Measures

Primary Outcomes (1)

  • Compare pEEG values in awake patients with developmental and epileptic encephalopathies

    pEEG will be measured using Sedline and BIS monitors alongside standard 21-lead EEG.

    60 minutes of monitoring in total - Sedline and BIS monitors will be fitted for 30 minutes each, in consecutive random order.

Study Arms (1)

Children (<16 years) with confirmed diagnosis of early onset EE or DEE due to any cause

Children (\<16 years old) with a confirmed diagnosis of early onset epileptic encephalopathy (EE) or Developmental and epileptic encephalopathy (DEE) due to any cause (prior to age 2 years).

Diagnostic Test: Monitoring of patients using electroencephalogram, a Bispectral Index (BIS) and Sedline monitors.

Interventions

This is an observational study of children under 16 years of age, who will be fitted with a 21-lead EEG and then, in consecutive random order, a BIS or Sedline monitor with measurements taken for 30 minutes with each monitor, 60 min in total. This will allow pEEG data to be measured against a corresponding continuous EEG. The depth of anaesthesia monitors used are Bispectral Index (BIS, Medtronic, Minneapolis, Minnesota, USA) and Sedline (Masimo, Irvine, California, USA).

Children (<16 years) with confirmed diagnosis of early onset EE or DEE due to any cause

Eligibility Criteria

Age0 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

20 eligible patients identified by the neurology department at Perth Children's Hospital and 20 eligible patients identified by the neurology department at Hospital das Clinicas HCFMUSP, Faculdade de Medicina, will be approached for the study.

You may qualify if:

  • Children (\<16 years old) with a confirmed diagnosis of early onset EE or DEE due to any cause (prior to age 2 years).

You may not qualify if:

  • Language barriers impeding data collection
  • Department for Child Protection and Family Support is involved in the care of the child.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Perth Children's Hospital

Perth, Western Australia, 6909, Australia

Location

Hospital das Clinicas, São Paulo, Sao Paulo

São Paulo, Brazil

Location

MeSH Terms

Conditions

Infantile Epileptic-Dyskinetic EncephalopathySpasms, Infantile

Condition Hierarchy (Ancestors)

Epilepsy, GeneralizedEpilepsyBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesEpileptic Syndromes

Central Study Contacts

Britta S von Ungern-Sternberg, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 6, 2026

First Posted

May 14, 2026

Study Start

May 20, 2026

Primary Completion (Estimated)

May 20, 2029

Study Completion (Estimated)

June 20, 2029

Last Updated

May 14, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations